RxDoctor Payments Data

Yebarna Rana, MD

Cardiology · Toms River, NJNPI 1053399170

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Abbott at 41.1% of the total. Reporting peaked in 2024 at $330 and has fallen 76.1% since, to $79 in 2025. That places this record below the midpoint for cardiology clinicians in NJ, where the typical reported total is $1,485.

$1,485in general payments, 2019–2025

Across 39 payments — averaging $38.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$611
  • E.r. Squibb & Sons, L.L.C.$282
  • Pfizer$208
  • Novartis$122
  • Johnson & Johnson$114
  • Amgen$111
  • plus $36 from 2 others

What the payments were for

  • Food & beverage$1,485100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott21$611
E.r. Squibb & Sons, L.L.C.5$282
Pfizer2$208
Novartis7$122
Johnson & Johnson1$114
Amgen1$111
Cvrx, Inc.1$20
Medtronic1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,485 in reported general payments places this provider in the 50th percentile of 31 cardiology providers in New Jersey.

See all cardiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$75,731
Medicare patients
1,297
Services billed
2,029

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban104$136,189
Ezetimibe114$3,044
Atorvastatin Calcium186$2,319
Metoprolol Succinate64$1,046
Rosuvastatin Calcium64$1,044
Potassium Chloride32$832
Amlodipine Besylate102$812
Metoprolol Tartrate67$515
Losartan Potassium57$488
Lisinopril21$462
ClopidogrelClopidogrel Bisulfate13$330
Chlorthalidone16$268
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid12$261
Amiodarone Hcl14$236
Pravastatin Sodium25$230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$208$136,189104 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 31 cardiology providers in New Jersey.

Other cardiology in Toms River

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →